BioCision appoints chief operating officer and expands corporate advisory board
BioCision LLC announced the expansion of its management team, with the appointment of industry veteran Hugh Douglas to the position of chief operating officer. The company also announced that it has added a group of leading industry experts to BioCision’s corporate advisory board. These appointments come as the company experiences rapid growth in new markets and regions.
Mr Douglas most recently led Bridge4Bio, LLC, a global business consulting group. Previously, he was managing director and president of Hoefer, Inc., a part of Harvard Bioscience. Mr Douglas was also vice president of the West Coast operations for Amersham Biosciences, now a part of GE Healthcare. He has been involved in start-ups, acquisitions and spin-outs and has broad experience in managing companies for growth and success. Mr Douglas holds a BA from the University of California, Berkeley and earned his MBA from Golden Gate University.
Other news from the department people
